Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
153
datasets available to search
ShareScore release 0.9.0
Dataset results
153 results for “interferon beta”
A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times
ClinicalTrials.gov study NCT01198132. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT01247324. IPD Sharing: Not stated. Countries: 32. Publications: 16.
Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of Multi-Organ Failure on Patients After Open Surgery for a RAAA
ClinicalTrials.gov study NCT03119701. IPD Sharing: NO. Countries: 3. Publications: 1.
Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a
ClinicalTrials.gov study NCT01514370. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19
ClinicalTrials.gov study NCT04465695. IPD Sharing: YES. Countries: 1. Publications: 5.
A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)
ClinicalTrials.gov study NCT00436826. IPD Sharing: Not stated. Countries: 4. Publications: 2.
A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT00883337. IPD Sharing: Not stated. Countries: 13. Publications: 2.
Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)
ClinicalTrials.gov study NCT01753570. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT00811395. IPD Sharing: Not stated. Countries: 7. Publications: 2.
A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection
ClinicalTrials.gov study NCT02491684. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Patients Having Acute Respiratory Distress Syndrome (ARDS)
ClinicalTrials.gov study NCT02622724. IPD Sharing: NO. Countries: 8. Publications: 2.
Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis
ClinicalTrials.gov study NCT00489489. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT01412333. IPD Sharing: Not stated. Countries: 24. Publications: 15.
Natalizumab De-escalation With Interferon Beta-1b
ClinicalTrials.gov study NCT01144052. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Interferon beta drives intestinal regeneration after radiation
<p>The cGAS-STING cytosolic DNA sensing pathway is critical for host defense. Here, we report that cGAS-STING–dependent type 1 interferon (IFN) response drives intestinal regeneration and animal recovery from radiation injury. STING deficiency has no effect on radiation-induced DNA damage or crypt apoptosis but abrogates epithelial IFN beta production, local inflammation, innate transcriptional response, and subsequent crypt regeneration. cGAS KO, IFNAR1 KO, or CCR2 KO also abrogates radiation-induced acute crypt inflammation and regeneration. Impaired intestinal regeneration and survival in STING-deficient mice are fully rescued by a single IFN beta treatment given 48 hours after irradiation but not by wild-type (WT) bone marrow. IFN treatment remarkably improves the survival of WT mice and Lgr5+ stem cell regeneration through elevated compensatory proliferation and more rapid DNA damage removal. Our findings support that inducible IFN production in the niche couples ISC injury and regeneration and its potential use to treat acute radiation injury.</p>
Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01701856. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis
ClinicalTrials.gov study NCT00303381. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease
ClinicalTrials.gov study NCT00304252. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients
ClinicalTrials.gov study NCT00151801. IPD Sharing: Not stated. Countries: 1. Publications: 9.
A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00441103. IPD Sharing: Not stated. Countries: 0. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.